Canada’s Bioscience Employers Recognized for Their Commitment to Diversity

BioTalent Canada announced the recipients of its inaugural I.D.E.A.L. Bioscience Employer™ designation. The I.D.E.A.L. Recognition Program recognizes organizations in the Canadian bio-economy who embody the principles of inclusion, diversity, equity and accessibility leadership (IDEAL), as best practices needed to promote growth and success in the biotech sector...READ MORE

Health Canada Accepts Nirsevimab Regulatory Submission for Infant RSV

Health Canada has accepted a New Drug Submission (NDS) for nirsevimab, the first investigational single-dose long-acting antibody designed for all infants to help protect against medically attended lower respiratory tract infections (LRTI) throughout their first respiratory syncytial virus (RSV) season. Nirsevimab is being developed by Sanofi and AstraZeneca...READ MORE

Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device

Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund. INOVAIT is a pan-Canadian network funded by the Government of Canada that invests strategically in projects at the intersection of advanced imaging, minimally-invasive therapies, and artificial intelligence (AI)...READ MORE

Algernon NeuroScience Doses First Subject in Phase 1 DMT Clinical Stroke Study

Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, is pleased to advise that its subsidiary, Algernon NeuroScience (AGN Neuro), has dosed the first subject in its Phase 1 clinical study of an intravenous formulation of AP-188 (“N,N-Dimethyltryptamine” or “DMT”) in the Netherlands. The trial is being conducted at the Centre for Human Drug Research in Leiden. DMT is a known psychedelic compound that is part of the tryptamine family...READ MORE

Northview Congratulates Neovasc Inc. on US $100M Transaction with Shockwave Medical

Northview would like to congratulate Neovasc Inc. on their approximately US $100 million transaction with Shockwave Medical.

Neovasc is a minimally invasive cardiac device company focusing on the treatment of refractory angina. Their patented device, the Reducer, is CE marked and approved for use in the EU and currently has a multicenter study underway in the US (COSIRA II)...READ MORE

Izotropic’s IzoView Breast CT Device to be Featured on Advancements TV Show in USA

Izotropic Corporation, a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, announces that IzoView will be featured on an upcoming segment of Advancements with Ted Danson via Amazon Prime Video and Bloomberg TV. The Company will update shareholders when filming for the segment commences on social media, and will disclose the airing date and time in a formal news release when determined...READ MORE

SFU Physicist Stephanie Simmons to Help Lead Canada’s New Quantum Strategy

SFU physicist Stephanie Simmons will help steer Canada’s new National Quantum Strategy as co-chair of its advisory council. The strategy, launched by the federal government and supported by a $360 million commitment, will help shape the future of quantum technologies in Canada. The role will mean working with top officials and experts in Canada and abroad to strengthen Canadian research, talent and commercialization...READ MORE

CLIC-01 Clinical Trial: Building BC Cancer’s Capabilities in Cutting-Edge Immunotherapy

BC Cancer’s immunotherapy team has developed the expertise and infrastructure to create genetically engineered immune cells (called CAR-T cells) for the treatment of life-threatening blood cancers. BC Cancer was the first academic group to produce and deliver CD19 CAR-T cells to cancer patients in Canada...READ MORE

Rostrum Medical Innovation Partners with Toronto General Hospital for Upcoming Evaluation of its’ VQm® System

Rostrum Medical® announced its partnership with Toronto General Hospital to begin an evaluation for its innovative device, the VQm® System. The agreement permits Toronto General Hospital to use the VQm® System in their Intensive Care Unit (ICU) to evaluate its performance in the critical care setting. This evaluation represents another milestone for Rostrum in its goal of empowering medical professionals with innovative solutions...READ MORE

Government of Canada Announces the Recipients of Support from INOVAIT’s Focus Fund

The pandemic has shown how important it is to ensure health care professionals have access to the proper tools and solutions to face all kinds of medical challenges and emergencies. That is why the Government of Canada continues to invest in the health care industry to ensure Canada remains a world leader in medical innovations...READ MORE

Government of Canada Boosts Life Sciences Innovation with Support for CIRION BioPharma Research Inc.

Supporting innovation contributes to economic development in Quebec’s regions. That is why the Honourable Pablo Rodriguez, Minister of Canadian Heritage and Quebec Lieutenant, announced, on behalf of the Honourable Pascale St–Onge, Minister of Sport and Minister responsible for CED, a repayable contribution of $600,000 for CIRION BioPharma Research Inc. This CED support will enable the business to become more competitive and accelerate its growth...READ MORE

Government of Canada Launches National Quantum Strategy to Create Jobs and Advance Quantum Technologies

Quantum science and technologies are at the leading edge of research and innovation, with enormous potential for commercialization and game-changing advances, including more effective drug design, better climate forecasting, improved navigation and innovations in clean technologies. The Government of Canada is committed to supporting the continued growth of this emerging sector as it helps drive Canada’s economy and supports highly skilled, well-paying jobs...READ MORE

Senior Scientist - Formulation

Acuitas Therapeutics is seeking a Senior Scientist to work in the Formulation Development Department, reporting to the Director, Formulation Development. The Senior Scientist will represent Formulation Development in internal and external partner programs and contribute scientifically to address any needs. The role holder will also exhibit strong leadership skills and be a mentor to members of Formulation Development. This positon will work closely with the Director to derive/execute departmental plans to better support success/growth and to achieve strategic objectives.

LEARN MORE

Research Associate / Scientist – Synthetic Chemistry

Acuitas Therapeutics is seeking a highly skilled MSc or PhD level scientist with expertise in synthetic organic and/or medicinal chemistry to work in the Chemistry Group, reporting to the Director, Chemistry. The role holder will be responsible for the design, synthesis and characterization of novel compounds in support of ongoing development of state-of-the-art LNP formulations for nucleic acid delivery. They will work as part of a cross-functional team, regularly interacting with the analytical chemistry, formulations and preclinical research groups.

LEARN MORE

Vice President, Investor Relations

Xenon Pharmaceuticals is seeking a Vice President, Investor Relations. The VP will be responsible for developing and executing a strategic investor relations program to communicate the company’s strategies and progress to the investment community. The role holder will work closely with Finance, Development, Commercial, Corporate Affairs, and the Senior Executive Team to develop an in-depth, comprehensive understanding of the company’s operations, financial performance, and strategies in order to articulate an accurate and concise message to the investment community.

LEARN MORE

Finch Media is a public relations, strategic communications and health communications agency that supports clients in a wide variety of sectors, including automotive, education, entertainment, biotech, life sciences, and consumer packaged goods (CPG). We help our clients identify, develop, and deploy their most compelling stories to make real connections, drive results, and have a lasting impact. Our expert team is based in Vancouver, and our work has benefitted numerous clients throughout Canada, the United States, and Europe.

As an award-winning agency, Finch Media is driven by client success. We pride ourselves on delivering value and the highest quality of services as we consistently strive to exceed client expectations. Get in touch with us today to see how we can help you spread the word and create meaning across all of your communications. Let us help you soar to new heights.

Visit Website

Sanofi Canada creates lifechanging and lifesaving healthcare products. We are dedicated to advancing healthcare for the whole person and every person, with products that empower self-care, prevent and treat diseases and help people living with illnesses – whether temporary, rare or lifelong – to live better.

Today, we are one of Canada’s leading investors in life sciences, manufacturing and research and development. Our work is based on science that Canadians can trust and a commitment to meeting new challenges head on through innovation and partnership.

Backed by a strong heritage in Canada and a global network spanning 170 countries, we are proud to fight for millions of lives every day.

Visit Website